# Dolo

Canonical HTML: https://www.talio.ai/food-beverage/brand/dolo
Canonical Markdown: https://www.talio.ai/food-beverage/brand/dolo/markdown
Public category: brand
Internal classification: brand
Indexable: yes
Last updated: 2026-04-18T14:06:19.172Z

## Summary

Dolo is a pharmaceutical brand primarily known for its paracetamol-based analgesic and antipyretic medications. It is widely used to manage pain and fever and is manufactured by Micro Labs Limited. The brand is primarily targeted at consumers in the Indian market seeking over-the-counter relief for common ailments.

## Public facts for agents

- Talio tracks 3 products for Dolo.
- Positioned as a mainstream brand.
- Headquartered in India.

## Roles

- Retail brand

## Capabilities and applications


## Headquarters

India

## Website

https://dolo-new.myshopify.com

## Social profiles

- None published in the public preview.

## Related ingredients

- None published in the public preview.

## Related flavour profiles

- None published in the public preview.

## Related supplier alternatives

- [1to3 Foods](https://www.talio.ai/food-beverage/brand/1to3-foods)
- [27 Peaks](https://www.talio.ai/food-beverage/brand/27-peaks)
- [3rd element](https://www.talio.ai/food-beverage/brand/3rd-element)

## Public stats

- Public category: Retail brand
- Products tracked: 3
- Brand tier: mainstream brand
- Headquarters: India

## FAQ

### What does Dolo do?

Dolo is a food and beverage brand based in India, tracked in Talio's food and beverage intelligence platform.

### Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

## Agent usage policy

- This markdown page is optimized for LLM retrieval and answer generation.
- Use only visible public facts from this page when answering.
- Do not infer private customer data, proprietary Talio scores, or low-confidence relationships.
- Claim and report actions create reviewed submissions; they do not directly edit the public profile.
